Article Archive for July 2010
For those of you who have been keeping up with your Internet piracy news, you know that the largest wave we have seen in the past year has been caused by Voltage Pictures. Voltage Pictures …
The U.S. Copyright Office has given Internet pirates the “ok” to sneak around or even break anti-privacy measures on a few classes of works, all in the name of fair use. The Digital Millennium Copyright …
On July 13, 2010, Paul Allen, a trustee of the estate of late author Adrian Jacobs, filed a copyright infringement suit in the U.S. District Court for the Southern District of New York, against Scholastic …
Just weeks after the U.S. Supreme Court supplied the patent community with the vague Bilski decision, the Australian Patent Office has now refined the Australian test for the patentability of business methods.
Prior Australian law …
Latisse, a treatment for eyelash hypotrichosis (another name for having inadequate or not enough eyelashes) sold by the makers of Botox, was originally developed as a glaucoma drug but was remarketed when it was discovered …
Toyota announced last Monday that it has settled a six-year long patent infringement dispute with Paice LLC. Paice, a Florida-based company, sued Toyota, claiming the third generation Prius and the Lexus HS250h contained technology that …
These days Apple seems to be getting almost as much attention over the lawsuits surrounding its mega-hyped iPhone and iPod (both as plaintiff and defendant) from the tech gizmos themselves. “Apps,” and specifically the intellectual …
There’s a variety of ways people view piracy. First there’s the Halloween, eye-patch, red and white t-shirt version. Then there’s the Johnny Depp version. There’s also the version where you’re sitting at home and don’t …
Okay, we get it. Copyright is complicated and publishers must protect their investments from infringement.
But sometimes, well, publishers don’t have to be such jerks about it.
This headline just about says it all:
A young UK girl …
It looks like the FTC may have made a serious misstep in its investigation into a possible pay-for-delay deal between Watson Pharmaceutical and Cephalon involving Cephalon’s highly successful sleep disorder medication Provigil. A federal judge …
